Dual Marker Test for First-Trimester Screening
The dual-marker test at 11-13 weeks + 6 days gestation should measure maternal serum PAPP-A (pregnancy-associated plasma protein-A) and free β-hCG (free beta-subunit of human chorionic gonadotropin), combined with ultrasound measurement of fetal nuchal translucency (NT) and maternal age to calculate risk for trisomy 21,18, and 13. 1, 2
Core Components of the Test
The combined first-trimester screening consists of:
Biochemical markers:
- PAPP-A (pregnancy-associated plasma protein-A)
- Free β-hCG (preferred over total/intact hCG at this gestational age)
Ultrasound measurement:
- Nuchal translucency (NT) thickness
Clinical factor:
- Maternal age
Why Free β-hCG Over Total hCG
Between 11 and 13 gestational weeks, free β-hCG is univariately a more discriminatory marker than total hCG. 2 When combined with maternal age, NT, and PAPP-A:
- Free β-hCG performs 2-3% better than total hCG at 11 weeks
- At 13 weeks, total hCG may perform only 1-2% better than free β-hCG
- The overall superior performance of free β-hCG makes it the preferred marker 2
Expected Performance
At a 5% false-positive rate, the detection rates for trisomy 21 are:
- 11 weeks: 86% detection rate
- 12 weeks: 84% detection rate
- 13 weeks: 82% detection rate 2
More recent data from large prospective studies shows even better performance when properly implemented 3:
- At 3% false-positive rate: 85-92% detection (depending on gestational week)
- At 5% false-positive rate: 90-94% detection
Pattern Recognition for Trisomies
Trisomy 21 (Down syndrome):
Trisomies 18 and 13:
- Decreased free β-hCG (opposite of trisomy 21)
- Decreased PAPP-A
- Increased NT
- Increased maternal age 5
Critical Implementation Details
Timing optimization: While the test window is 11-13+6 weeks, biochemical marker performance varies by gestational age. PAPP-A shows maximum discrimination at 9-10 weeks, while free β-hCG discrimination increases linearly through the first trimester 6. However, for practical single-visit combined screening at 11-13+6 weeks, the test performs well when both markers are measured simultaneously with NT 1, 2.
Marker adjustment: The laboratory must adjust MoM (multiples of the median) values for:
- Maternal weight
- Ethnicity/racial origin
- Smoking status
- Method of conception
- Parity 3
Common Pitfalls to Avoid
- Do not use total/intact hCG instead of free β-hCG at 11-12 weeks, as this reduces detection rates by 2-3% 2
- Ensure NT measurement quality control - laboratories should monitor sonographer performance and have protocols to address discrepancies 1
- Do not screen before 11 weeks - the combined test is validated for 11-13+6 weeks specifically 1, 2
Follow-Up for Screen-Positive Results
Screen-positive patients should be offered:
- Genetic counseling
- Non-invasive prenatal testing (NIPT) as a secondary screen
- Diagnostic testing (CVS or amniocentesis) 4
Recent data shows that among high-risk first-trimester screens, NIPT can further refine risk before proceeding to invasive diagnostic testing 4.